Projects per year
Personal profile
Education
- 2018 PhD, Graduate Institute of Clinical Medicine, College of Medicine, National Yang-Ming University
- 2003 MD, College of Medicine, National Defense Medical Center
Experience
- Director, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Director, Division of Gynecology, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Attending, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- 2023.02- Associate Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- Assistant Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- 2012.05-2019.03 Attending, Department of Obstetrics & Gynecology,Taipei Veterans General Hospital
Fingerprint
Dive into the research topics where Kuo-Chang Wen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Detection &. Risk Assessment of Ovarian Tumors by Dna Methylation Biomarkers from Cervical Swab
Wen, K.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Detection &. Risk Assessment of Ovarian Tumors by Dna Methylation Biomarkers from Cervical Swab
Wen, K.-C. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of New Dna Methylation Biomarkers to Improve the Performance of Self-Sampling Mpap (Mpap 2.0)
Wen, K.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of New Dna Methylation Biomarkers to Improve the Performance of Self-Sampling Mpap (Mpap 2.0) (1/2)
Wen, K.-C. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Development of an Epigenetic Classification of High Grade Serous Ovarian Carcinoma (Hgsoc) Using Cancer Stem Cell Differentiation
Wen, K.-C. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Exploring potential methylation markers for ovarian cancer from cervical scraping samples
Lien, J. Y., Hii, L. A., Su, P. H., Chen, L. Y., Wen, K. C., Lai, H. C. & Wang, Y. C., Dec 2025, In: Human Genomics. 19, 1, 56.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clinical outcomes
Chen, L. Y., Chen, H. Y., Lai, H. C., Lin, S. F., Wen, K. C., Darmawi & Liew, P. L., 2025, In: Taiwanese Journal of Obstetrics and Gynecology. 64, 1, p. 110-119 10 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor
Chen, L. Y., Shen, Y. A., Chu, L. H., Su, P. H., Wang, H. C., Weng, Y. C., Lin, S. F., Wen, K. C., Liew, P. L. & Lai, H. C., Jun 2024, In: Antioxidants. 13, 6, 735.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Correction to: In vitro drug testing using patient-derived ovarian cancer organoids (Journal of Ovarian Research, (2024), 17, 1, (194), 10.1186/s13048-024-01520-2)
Chen, L. Y., Chou, Y. T., Liew, P. L., Chu, L. H., Wen, K. C., Lin, S. F., Weng, Y. C., Wang, H. C., Su, P. H. & Lai, H. C., Dec 2024, In: Journal of Ovarian Research. 17, 1, 243.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
In vitro drug testing using patient-derived ovarian cancer organoids
Chen, L. Y., Chou, Y. T., Liew, P. L., Chu, L. H., Wen, K. C., Lin, S. F., Weng, Y. C., Wang, H. C., Su, P. H. & Lai, H. C., Dec 2024, In: Journal of Ovarian Research. 17, 1, 194.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor) & Wen, K.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
Dataset
-
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Wu, A. T. H. (Creator), Yeung, S.-C. J. (Contributor), Wen, K.-C. (Creator), Chou, P.-C. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor) & Sung, P.-L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845531.v1, https://doi.org/10.6084%2Fm9.figshare.12845531.v1
Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset
-
Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Chou, P.-C. (Contributor), Wen, K.-C. (Creator), Lee, M.-H. (Contributor), Lin, J.-H. (Contributor), Sung, P.-L. (Contributor), Yeung, S.-C. J. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845525.v1, https://doi.org/10.6084%2Fm9.figshare.12845525.v1
Dataset